Axorus

Axorus is a French-based startup that specializes in the development of a High Acuity Artificial Retina. This innovative product is designed to aid patients suffering from Age-Related Macular Degeneration (AMD) and Retinitis Pigmentosa, two conditions that cause severe vision loss. The company's groundbreaking technology is a result of a partnership with Boston University and uses patented photoacoustic technology.

In simple terms, Axorus is creating an artificial retina that can be implanted into the eye to restore sight for people with damaged photoreceptors, the cells in the retina that respond to light. The artificial retina works by converting light into a signal that the brain can interpret, effectively acting as a substitute for the damaged photoreceptors.

But Axorus's vision extends beyond just the retina. The company aims to leverage its technology to develop a range of medical implants to treat symptoms of neurodegenerative diseases, with the ultimate goal of improving the quality of life for patients. In essence, Axorus is looking to pioneer a new neurotech industry that allows people to purchase 'spare parts' to regain lost capabilities.

The company's business model revolves around the development and sale of these medical implants. Their primary market is patients suffering from vision loss due to AMD and Retinitis Pigmentosa, but they also aim to serve those affected by various neurodegenerative diseases.

Keywords: Artificial Retina, Age-Related Macular Degeneration, Retinitis Pigmentosa, Neurotech Industry, Medical Implants, Neurodegenerative Diseases, Photoacoustic Technology, Vision Restoration, Photoreceptors, Neurostimulator.